Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coya Therapeutics (COYA) Revenue (2023 - 2025)

Coya Therapeutics' Revenue history spans 3 years, with the latest figure at $3.6 million for Q3 2025.

  • For Q3 2025, Revenue changed N/A year-over-year to $3.6 million; the TTM value through Sep 2025 reached $4.0 million, down 58.26%, while the annual FY2024 figure was $3.6 million, 40.79% down from the prior year.
  • Revenue for Q3 2025 was $3.6 million at Coya Therapeutics, up from $163616.0 in the prior quarter.
  • Across five years, Revenue topped out at $6.0 million in Q4 2023 and bottomed at $1952.0 in Q4 2024.
  • The 3-year median for Revenue is $257884.0 (2025), against an average of $1.9 million.
  • The largest annual shift saw Revenue crashed 99.97% in 2024 before it soared 103.32% in 2025.
  • A 3-year view of Revenue shows it stood at $6.0 million in 2023, then plummeted by 99.97% to $1952.0 in 2024, then surged by 182494.98% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for COYA's Revenue are $3.6 million (Q3 2025), $163616.0 (Q2 2025), and $257884.0 (Q1 2025).